Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres

Nam Hyuk Cho, Seung Yong Seong, Kyung Hee Chun, Yong Hee Kim, Ick Chan Kwon, Byung-Yoon Ahn, Seo Young Jeong

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

A novel mucosal immunization was examined using biocompatible and biodegradable alginate microspheres containing a conjugate of polysaccharide antigen and cholera toxin B subunit (CTB). In order to prepare the alginate microspheres with diameters of less than 5 μm, a new diffusion-controlled interfacial gelation technique was developed. Also, in order to improve the mucosal immune response, a pneumococcal capsular polysaccharide type 19 (PS19) was conjugated to the CTB (PS19-CTB). This conjugate was subsequently encapsulated into the alginate microspheres. The loading content of PS19-CTB to the alginate microspheres was 60%. An in vitro sustained release pattern was observed with the antigen-loaded microspheres, showing 80% antigen release within one day. Mucosal and systemic immunities following oral immunization with the alginate microspheres were studied. Balb/c mice were immunized perorally three times at intervals of two weeks. Peroral immunization with 25 μg of PS19-CTB entrapped in the alginate microspheres evoked both the mucosal IgA and systemic IgM responses to PS19 in small intestine and in sera, respectively. The results suggest that both the mucosal and systemic antibody responses could be induced by oral administration of the PS19-CTB antigen entrapped in alginate microspheres.

Original languageEnglish
Pages (from-to)215-224
Number of pages10
JournalJournal of Controlled Release
Volume53
Issue number1-3
DOIs
Publication statusPublished - 1998 Apr 30

Fingerprint

Microspheres
Polysaccharides
Cholera Toxin
Immunization
Proteins
Antigens
Mucosal Immunity
alginic acid
Immunoglobulin A
Small Intestine
Antibody Formation
Immunoglobulin M
Oral Administration
Serum

Keywords

  • Alginate microsphere
  • Mucosal immunization
  • Oral vaccine
  • Pneumococcal pneumonia

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. / Cho, Nam Hyuk; Seong, Seung Yong; Chun, Kyung Hee; Kim, Yong Hee; Kwon, Ick Chan; Ahn, Byung-Yoon; Jeong, Seo Young.

In: Journal of Controlled Release, Vol. 53, No. 1-3, 30.04.1998, p. 215-224.

Research output: Contribution to journalArticle

Cho, Nam Hyuk ; Seong, Seung Yong ; Chun, Kyung Hee ; Kim, Yong Hee ; Kwon, Ick Chan ; Ahn, Byung-Yoon ; Jeong, Seo Young. / Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. In: Journal of Controlled Release. 1998 ; Vol. 53, No. 1-3. pp. 215-224.
@article{83b9942cd0564cc99c7fcbe33d4f3803,
title = "Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres",
abstract = "A novel mucosal immunization was examined using biocompatible and biodegradable alginate microspheres containing a conjugate of polysaccharide antigen and cholera toxin B subunit (CTB). In order to prepare the alginate microspheres with diameters of less than 5 μm, a new diffusion-controlled interfacial gelation technique was developed. Also, in order to improve the mucosal immune response, a pneumococcal capsular polysaccharide type 19 (PS19) was conjugated to the CTB (PS19-CTB). This conjugate was subsequently encapsulated into the alginate microspheres. The loading content of PS19-CTB to the alginate microspheres was 60{\%}. An in vitro sustained release pattern was observed with the antigen-loaded microspheres, showing 80{\%} antigen release within one day. Mucosal and systemic immunities following oral immunization with the alginate microspheres were studied. Balb/c mice were immunized perorally three times at intervals of two weeks. Peroral immunization with 25 μg of PS19-CTB entrapped in the alginate microspheres evoked both the mucosal IgA and systemic IgM responses to PS19 in small intestine and in sera, respectively. The results suggest that both the mucosal and systemic antibody responses could be induced by oral administration of the PS19-CTB antigen entrapped in alginate microspheres.",
keywords = "Alginate microsphere, Mucosal immunization, Oral vaccine, Pneumococcal pneumonia",
author = "Cho, {Nam Hyuk} and Seong, {Seung Yong} and Chun, {Kyung Hee} and Kim, {Yong Hee} and Kwon, {Ick Chan} and Byung-Yoon Ahn and Jeong, {Seo Young}",
year = "1998",
month = "4",
day = "30",
doi = "10.1016/S0168-3659(97)00255-1",
language = "English",
volume = "53",
pages = "215--224",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres

AU - Cho, Nam Hyuk

AU - Seong, Seung Yong

AU - Chun, Kyung Hee

AU - Kim, Yong Hee

AU - Kwon, Ick Chan

AU - Ahn, Byung-Yoon

AU - Jeong, Seo Young

PY - 1998/4/30

Y1 - 1998/4/30

N2 - A novel mucosal immunization was examined using biocompatible and biodegradable alginate microspheres containing a conjugate of polysaccharide antigen and cholera toxin B subunit (CTB). In order to prepare the alginate microspheres with diameters of less than 5 μm, a new diffusion-controlled interfacial gelation technique was developed. Also, in order to improve the mucosal immune response, a pneumococcal capsular polysaccharide type 19 (PS19) was conjugated to the CTB (PS19-CTB). This conjugate was subsequently encapsulated into the alginate microspheres. The loading content of PS19-CTB to the alginate microspheres was 60%. An in vitro sustained release pattern was observed with the antigen-loaded microspheres, showing 80% antigen release within one day. Mucosal and systemic immunities following oral immunization with the alginate microspheres were studied. Balb/c mice were immunized perorally three times at intervals of two weeks. Peroral immunization with 25 μg of PS19-CTB entrapped in the alginate microspheres evoked both the mucosal IgA and systemic IgM responses to PS19 in small intestine and in sera, respectively. The results suggest that both the mucosal and systemic antibody responses could be induced by oral administration of the PS19-CTB antigen entrapped in alginate microspheres.

AB - A novel mucosal immunization was examined using biocompatible and biodegradable alginate microspheres containing a conjugate of polysaccharide antigen and cholera toxin B subunit (CTB). In order to prepare the alginate microspheres with diameters of less than 5 μm, a new diffusion-controlled interfacial gelation technique was developed. Also, in order to improve the mucosal immune response, a pneumococcal capsular polysaccharide type 19 (PS19) was conjugated to the CTB (PS19-CTB). This conjugate was subsequently encapsulated into the alginate microspheres. The loading content of PS19-CTB to the alginate microspheres was 60%. An in vitro sustained release pattern was observed with the antigen-loaded microspheres, showing 80% antigen release within one day. Mucosal and systemic immunities following oral immunization with the alginate microspheres were studied. Balb/c mice were immunized perorally three times at intervals of two weeks. Peroral immunization with 25 μg of PS19-CTB entrapped in the alginate microspheres evoked both the mucosal IgA and systemic IgM responses to PS19 in small intestine and in sera, respectively. The results suggest that both the mucosal and systemic antibody responses could be induced by oral administration of the PS19-CTB antigen entrapped in alginate microspheres.

KW - Alginate microsphere

KW - Mucosal immunization

KW - Oral vaccine

KW - Pneumococcal pneumonia

UR - http://www.scopus.com/inward/record.url?scp=0032580501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032580501&partnerID=8YFLogxK

U2 - 10.1016/S0168-3659(97)00255-1

DO - 10.1016/S0168-3659(97)00255-1

M3 - Article

C2 - 9741929

AN - SCOPUS:0032580501

VL - 53

SP - 215

EP - 224

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 1-3

ER -